Gene expression changes during cataract progression in Sparc null mice: Differential regulation of mouse globins in the lens

Molecular Vision

Volumn 10, Issue , 2004, Pages 490-511

  Mansergh, Fiona C ^a   Wride, Michael A ^b   Walker, Veronica E ^a   Adams, Steffan ^a   Hunter, Susan M ^a   Evans, Martin J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLOBIN; OSTEONECTIN; MESSENGER RNA; PRIMER DNA;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CONTROLLED STUDY; DOWN REGULATION; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN GENOME PROJECT; HYBRIDIZATION; IMMUNE RESPONSE; KNOCKOUT MOUSE; LENS; MALE; MOLECULAR CLONING; MOUSE; MOUSE STRAIN; NONHUMAN; NULL ALLELE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FOLDING; PROTEIN MICROARRAY; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; UPREGULATION; ANIMAL; C57BL MOUSE; CHEMISTRY; DISEASE COURSE; DNA MICROARRAY; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CATARACT; DISEASE PROGRESSION; DNA PRIMERS; DOWN-REGULATION; EXPRESSED SEQUENCE TAGS; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOTYPE; GLOBINS; LENS, CRYSTALLINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEONECTIN; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 4043137958     PISSN: 10900535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Wride MA. Cellular and molecular features of lens differentiation: a review of recent advances. Differentiation 1996; 61:77-93.
2. Piatigorsky J. Lens differentiation in vertebrates. A review of cellular and molecular features. Differentiation 1981; 19:134-53.
3. Wride MA. Minireview: apoptosis as seen through a lens. Apoptosis 2000; 5:203-9.
4. Bassnett S. Lens organelle degradation. Exp Eye Res 2002; 74:1-6.
5. Norose K, Lo WK, Clark JI, Sage EH, Howe CC. Lenses of SPARC-null mice exhibit an abnormal cell surface-basement membrane interface. Exp Eye Res 2000; 71:295-307.
6. Yan Q, Clark JI, Wight TN, Sage EH. Alterations in the lens capsule contribute to cataractogenesis in SPARC-null mice. J Cell Sci 2002; 115:2747-56.
7. Francis PJ, Moore AT. Genetics of childhood cataract. Curr Opin Ophthalmol 2004; 15:10-5.
8. Minassian DC, Reidy A, Desai P, Farrow S, Vafidis G, Minassian A. The deficit in cataract surgery in England and Wales and the escalating problem of visual impairment: epidemiological modelling of the population dynamics of cataract. Br J Ophthalmol 2000; 84:4-8.
9. Harding J. Cataract: biochemistry, epidemiology, and pharmacology. 1st ed. London: Chapman and Hall; 1991.
10. Derham BK, Harding JJ. Effects of modifications of alpha-crystallin on its chaperone and other properties. Biochem J 2002; 364:711-7.
11. Mason IJ, Taylor A, Williams JG, Sage H, Hogan BL. Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial cell 'culture shock' glycoprotein of Mr 43,000. EMBO J 1986; 5:1465-72.
12. Lane TF, Sage EH. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J 1994; 8:163-73.
13. Yan Q, Blake D, Clark JI, Sage EH. Expression of the matricellular protein SPARC in murine lens: SPARC is necessary for the structural integrity of the capsular basement membrane. J Histochem Cytochem 2003; 51:503-11.
14. Brekken RA, Sage EH. SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol 2001; 19:816-27.
15. Gilmour DT, Lyon GJ, Carlton MB, Sanes JR, Cunningham JM, Anderson JR, Hogan BL, Evans MJ, Colledge WH. Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J 1998; 17:1860-70.
16. Norose K, Clark JI, Syed NA, Basu A, Heber-Katz E, Sage EH, Howe CC. SPARC deficiency leads to early-onset cataractogenesis. Invest Ophthalmol Vis Sci 1998; 39:2674-80.
17. Bassuk JA, Birkebak T, Rothmier JD, Clark JM, Bradshaw A, Muchowski PJ, Howe CC, Clark JI, Sage EH. Disruption of the Sparc locus in mice alters the differentiation of lenticular epithelial cells and leads to cataract formation. Exp Eye Res 1999; 68:321-31.
18. Delany AM, Amling M, Priemel M, Howe C, Baron R, Canalis E. Osteopenia and decreased bone formation in osteonectin-deficient mice. J Clin Invest 2000; 105:915-23. Erratum in: J Clin Invest 2000; 105:1325.
19. Kantorow M, Huang Q, Yang XJ, Sage EH, Magabo KS, Miller KM, Horwitz J. Increased expression of osteonectin/SPARC mRNA and protein in age-related human cataracts and spatial expression in the normal human lens. Mol Vis 2000; 6:24-9 .
20. Kantorow M, Horwitz J, Carper D. Up-regulation of osteonectin/SPARC in age-related cataractous human lens epithelia. Mol Vis 1998; 4:17 .
21. Robinson ML, Holmgren A, Dewey MJ. Genetic control of ocular morphogenesis: defective lens development associated with ocular anomalies in C57BL/6 mice. Exp Eye Res 1993; 56:7-16.
22. Sandilands A, Wang X, Hutcheson AM, James J, Prescott AR, Wegener A, Pekny M, Gong X, Quinlan RA. Bfsp2 mutation found in mouse 129 strains causes the loss of CP49 and induces vimentin-dependent changes in the lens fibre cell cytoskeleton. Exp Eye Res 2004; 78:109-23.
23. Alizadeh A, Clark J, Seeberger T, Hess J, Blankenship T, FitzGerald PG. Characterization of a mutation in the lens-specific CP49 in the 129 strain of mouse. Invest Ophthalmol Vis Sci 2004; 45:884-91.
24. Graw J. The genetic and molecular basis of congenital eye defects. Nat Rev Genet 2003; 4:876-88.
25. Wilson AS, Hobbs BG, Speed TP, Rakoczy PE. The microarray: potential applications for ophthalmic research. Mol Vis 2002; 8:259-70 .
26. Wride MA, Mansergh FC, Adams S, Everitt R, Minnema SE, Rancourt DE, Evans MJ. Expression profiling and gene discovery in the mouse lens. Mol Vis 2003; 9:360-96 .
27. Tanaka TS, Jaradat SA, Lim MK, Kargul GJ, Wang X, Grahovac MJ, Pantano S, Sano Y, Piao Y, Nagaraja R, Doi H, Wood WH 3rd, Becker KG, Ko MS. Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray. Proc Natl Acad Sci U S A 2000; 97:9127-32.
28. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001; 29:365-71.
29. Schiemann BJ, Neil JR, Schiemann WP. SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system. Mol Biol Cell 2003; 14:3977-88.
30. Bradshaw AD, Puolakkainen P, Dasgupta J, Davidson JM, Wight TN, Helene Sage E. SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J Invest Dermatol 2003; 120:949-55.
31. Boskey AL, Moore DJ, Amling M, Canalis E, Delany AM. Infrared analysis of the mineral and matrix in bones of osteonectin-null mice and their wildtype controls. J Bone Miner Res 2003; 18:1005-11.
32. Nishimoto S, Kawane K, Watanabe-Fukunaga R, Fukuyama H, Ohsawa Y, Uchiyama Y, Hashida N, Ohguro N, Tano Y, Morimoto T, Fukuda Y, Nagata S. Nuclear cataract caused by a lack of DNA degradation in the mouse eye lens. Nature 2003; 424:1071-4.
33. Van Der Woerdt A. Lens-induced uveitis. Vet Ophthalmol 2000; 3:227-234.
34. Taneda S, Pippin JW, Sage EH, Hudkins KL, Takeuchi Y, Couser WG, Alpers CE. Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol 2003; 14:968-80.
35. Kihm AJ, Kong Y, Hong W, Russell JE, Rouda S, Adachi K, Simon MC, Blobel GA, Weiss MJ. An abundant erythroid protein that stabilizes free alpha-haemoglobin. Nature 2002; 417:758-63.
36. Hawse JR, Hejtmancik JF, Huang Q, Sheets NL, Hosack DA, Lempicki RA, Horwitz J, Kantorow M. Identification and functional clustering of global gene expression differences between human age-related cataract and clear lenses. Mol Vis 2003; 9:515-37 .
37. Babalola OE, Danboyi P, Abiose AA. Hereditary congenital cataracts associated with sickle cell anaemia in a Nigerian family. Trop Doct 2000; 30:12-4.
38. Bloomfield SE, Markenson AL, Miller DR, Peterson CM. Lens opacities in thalassemia. J Pediatr Ophthalmol Strabismus 1978; 15:154-6.
39. Konkel DA, Maizel JV Jr, Leder P. The evolution and sequence comparison of two recently diverged mouse chromosomal beta - globin genes. Cell 1979; 18:865-73.
40. Drewell RA, Arney KL, Arima T, Barton SC, Brenton JD, Surani MA. Novel conserved elements upstream of the H19 gene are transcribed and act as mesodermal enhancers. Development 2002; 129:1205-13.
41. Oppermann B, Zhang W, Magabo K, Kantorow M. Identification and spatial analysis of metallothioneins expressed by the adult human lens. Invest Ophthalmol Vis Sci 2001; 42:188-93.
42. Hawse JR, Cumming JR, Oppermann B, Sheets NL, Reddy VN, Kantorow M. Activation of metallothioneins and alpha-crystallin/sHSPs in human lens epithelial cells by specific metals and the metal content of aging clear human lenses. Invest Ophthalmol Vis Sci 2003; 44:672-9.
43. Spector A. Review: Oxidative stress and disease. J Ocul Pharmacol Ther 2000; 16:193-201.
44. Ihara Y, Suzuki YJ, Kitta K, Jones LR, Ikeda T. Modulation of gene expression in transgenic mouse hearts overexpressing calsequestrin. Cell Calcium 2002; 32:21-9.
45. MacKinney AA. Hematology for Students. 1st ed. New York: Taylor and Francis; 2002.
46. Sano H, Hsu DK, Apgar JR, Yu L, Sharma BB, Kuwabara I, Izui S, Liu FT. Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest 2003; 112:389-97.
47. Lefrancois S, May T, Knight C, Bourbeau D, Morales CR. The lysosomal transport of prosaposin requires the conditional interaction of its highly conserved d domain with sphingomyelin. J Biol Chem 2002; 277:17188-99.
48. Golembieski WA, Rempel SA. cDNA array analysis of SPARC-modulated changes in glioma gene expression. J Neurooncol 2002; 60:213-26.
49. Hohenadl C, Mann K, Mayer U, Timpl R, Paulsson M, Aeschlimann D. Two adjacent N-terminal glutamines of BM-40 (osteonectin, SPARC) act as amine acceptor sites in transglutaminaseC-catalyzed modification. J Biol Chem 1995; 270:23415-20.